Results 1 to 10 of about 284,370 (314)

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

Cancers, 2021
Elisa Agostinetto, Mattia Rediti, Danai Fimereli   +2 more
exaly  

HER2-low expression in patients with advanced or metastatic solid tumors

Annals of Oncology, 2023
Ying Yuan
exaly  

Targeting HER2 heterogeneity in breast cancer

Cancer Treatment Reviews, 2021
Erika Hamilton, Mythili Shastry
exaly  

The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status

Breast Cancer, 2021
Nanae Horisawa, Kazuki Nozawa, Yuka Endo
exaly  

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Cancer Cell, 2018
Kumar Prabhash, Mbbs,, Dm, Marco Mravic, Steffen Durinck   +2 more
exaly  

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis

Cancer Treatment Reviews, 2020
Francesco Schettini, Tomás Pascual, Benedetta Conte   +2 more
exaly  

Inhibition of HER2‐Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2‐Glycan‐Imprinted Nanoparticles

Angewandte Chemie - International Edition, 2019
Wei Li, Rongrong Xing, Zhen Liu
exaly  

HER2-targeted therapies — a role beyond breast cancer

Nature Reviews Clinical Oncology, 2019
Do-Youn Oh, Yung-Jue Bang
exaly  

The role of HER2 in cancer therapy and targeted drug delivery

Journal of Controlled Release, 2010
Wan-Yi Tai, Rubi Mahato, Kun Cheng
exaly  

Treatment of HER2-positive breast cancer: current status and future perspectives

Nature Reviews Clinical Oncology, 2011
Carlos L Arteaga, Fabio Puglisi, Luca Gianni   +2 more
exaly